← Back to Search

Electrical Stimulation

Transcutaneous Electrical Nerve Stimulation for Spinal Cord Injury (SCI Trial)

N/A
Recruiting
Led By Caitlyn Peters, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
individuals with traumatic spinal cord injuries at or above T6
non-ambulatory
Must not have
Acute illness or infection
Documented history of controlled or uncontrolled diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, up to 2 years

Summary

This trial is testing a new way to help people with spinal cord injuries who often have low blood pressure.

Who is the study for?
This trial is for adults over 18 with traumatic spinal cord injuries at or above T6, who are not able to walk and have had the injury for more than a year. They must be able to give consent, not use a ventilator, and have low blood pressure. People with recent thrombosis, severe contractures, infections, diabetes, other neurological diseases besides spinal cord injury or cardiovascular disease cannot join.
What is being tested?
The study tests how skin stimulation on the back can help control blood pressure in people with spinal cord injuries. It aims to find the best spots for electrode placement and the right settings for frequency and amplitude of stimulation that could improve their cardiovascular health.
What are the potential side effects?
While specific side effects are not detailed here, transcutaneous stimulation may cause discomfort at the site of application or skin irritation. There might also be potential unknown risks related to changes in blood pressure regulation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My spinal cord injury is at or above the T6 level.
Select...
I cannot walk by myself.
Select...
I am over 18 years old.
Select...
My spinal cord injury is at or above the T6 level.
Select...
My injury occurred over a year ago.
Select...
I cannot walk by myself.
Select...
My spinal injury is classified as severe to moderate.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently dealing with an acute illness or infection.
Select...
I have a history of diabetes, whether it's under control or not.
Select...
I have a neurological condition that is not a spinal cord injury.
Select...
I have a history of heart or blood vessel diseases.
Select...
I have had a blood clot or severe muscle tightness in the past year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Amplitude of TSCS
Electrode placement
Secondary study objectives
Concentration of Aldosterone
Concentration of Norepinephrine
Concentration of Renin
+2 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: With StimulationActive Control2 Interventions
Participant will complete an orthostatic challenge with transcutaneous stimulation.
Group II: Without StimulationPlacebo Group1 Intervention
Participant will complete an orthostatic challenge without transcutaneous stimulation.

Find a Location

Who is running the clinical trial?

Kessler FoundationOTHER
181 Previous Clinical Trials
11,069 Total Patients Enrolled
VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,794 Total Patients Enrolled
Caitlyn Peters, PhDPrincipal InvestigatorJames J. Peters Veterans Affairs Medical Center

Media Library

DS8R (Electrical Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05180227 — N/A
Spinal Cord Injury Research Study Groups: With Stimulation, Without Stimulation
Spinal Cord Injury Clinical Trial 2023: DS8R Highlights & Side Effects. Trial Name: NCT05180227 — N/A
DS8R (Electrical Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05180227 — N/A
~3 spots leftby Nov 2025